AVXL CIK: 1314052

Anavex Life Sciences Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.4
FY22:
−24.2
FY23:
−27.8
FY24:
−30.8
FY25:
−39.0
Change from FY21 to FY25
millions USD
FY21:
153
FY22:
21.3
FY23:
29.7
FY24:
12.0
FY25:
9.43

All amounts in millions USD Data source:SEC EDGAR